Faster and safer safety cabinet fumigation
Hydrogen peroxide system offers alternative to toxic formaldehyde fumigation of safety cabinets
An easier and faster alternative to formaldehyde fumigation, the Skanair DECOSIS is a mobile unit used directly in the lab, and connected to the safety cabinet via two tubes. It functions autonomously thanks to a control system and catalytic converter.
Because it uses hydrogen peroxide (H2O2) as a biocide, decomposition products are unproblematic, and maintenance work can subsequently be safely carried out on the decontaminated cabinet.
The unit can be used to decontaminate microbiological safety cabinets in advance of maintenance work, when changing job or location, in preparation for disposal, or in the event of breakdowns or accidents.
It can also be used to decontaminate incubators, air locks and small isolators.
The cabinet continues to run in reduced mode throughout the procedure. The trained maintenance technician enters the corresponding facility parameters at a control system display, together with the quantity of H2O2 defined on the basis of the Skanair DECOSIS validation.
The process starts at the touch of a button, and runs completely automatically: the internal ventilation unit maintains slight negative pressure and feeds H2O2 vapour through the front cover into the cabinet, continuously circulating it inside the cabinet to reach all contaminated areas. The exhaust air through the cabinet‘s HEPA filter is then fed back into the Skanair DECOSIS via the second tube to be recirculated.
The decontamination phase is followed by the flushing phase: any biocides in the exhaust air from the cabinet are removed inside the Skanair DECOSIS via a catalytic converter and a final HEPA filter. This air can then be released directly into the lab, without having to be extracted via the building exhaust air system.
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
Upcoming event
You may also like
Manufacturing
Upperton submits MHRA application for new sterile manufacturing facility in Nottingham
UK CDMO Upperton Pharma Solutions has filed for regulatory approval from the MHRA for its new 7000 sqft sterile manufacturing facility, designed to meet updated EU GMP Annex 1 standards and expand early-phase clinical manufacturing capacity
Regulatory
UK unveils regulatory pathway to bring space-manufactured medicines to market
The UK Space Agency and MHRA have outlined new guidance, case studies and a regulatory sandbox to support companies developing pharmaceuticals in microgravity, aiming to accelerate the path from in-orbit manufacturing to patient access
Regulatory
Ananda Pharma receives MHRA and HRA approval for Phase II ENDOCAN trial in endometriosis
UK biopharmaceutical company Ananda Pharma has received regulatory and ethics approval to begin a Phase II clinical trial investigating its proprietary cannabidiol (CBD) therapy for the management of endometriosis-associated pain